SHENZHEN, China, CAMBRIDGE, Mass. and SHERMAN OAKS, Calif. — BGI Genomics, a global leader in Next Generation Sequencing Services, and Sanguine BioSciences, Inc., a builder of data-integrated patient communities, have joined forces to develop a database of combined genomic and clinical data to increase the speed and efficiency of Precision Clinical Trial Recruitment. For their […]

SHENZHEN, HEIDELBERG – BGI, one of the world’s leading genomics organisations, headquartered in Shenzhen, Guangdong, P. R. China, and Hummingbird Diagnostics GmbH, Heidelberg, Germany, an innovator in miRNA-based diagnostic tests from blood for early disease detection, today announced that they have signed a Memorandum of Understanding (MoU) intending to establish a broad collaboration in miRNA-based […]

MANASSAS, VA — ATCC, a global leader in biological materials development, management, and standards; and the Association of Biomolecular Resource Facilities Metagenomics Research Group (ABRF-MGRG), a collaboration dedicated to the advancement of metagenomic methodologies; today announced the launch of three new microbiome reference standards comprising genomic DNA prepared from microorganisms prevalent in extreme environments. One […]

GenDx has signed a global reseller agreement with Thermo Fisher Scientific assigning GenDx as a nonexclusive reseller of Applied Biosystems™ QuantStudio™ real-time PCR systems, including the QuantStudio 5, QuantStudio 6 Flex, and QuantStudio 7 Flex. Under the agreement, local distributors of GenDx are authorized to supply the above-mentioned QuantStudio systems and service contracts in their […]

The FDA-approved, next-generation sequencing-based companion diagnostic rapidly identifies non-small cell lung cancer patients eligible for targeted therapies Ft. Myers, Florida –NeoGenomics, Inc. (NASDAQ: NEO), ), a leading global specialty oncology testing laboratory, has signed an agreement with Thermo Fisher Scientific to join the Next-Generation Sequencing Companion Dx Center of Excellence Program (COEP). NeoGenomics is one of […]

Combines Molecular Spectroscopy Techniques with Analytical Chemistry Expertise to Uncover Nutritional Value of Food WALTHAM, Mass–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced a collaboration with TeakOrigin, a company that integrates technology and data platforms to serve as a detector for food authenticity and quality. PerkinElmer’s cutting-edge molecular spectroscopy instrumentation, […]

Location: Cambridge Breadth of research use rights now expanded to include multiple new species Grant of rights to have products made and sold by partners Grant of sub-licensed rights to one spin-out company Cambridge, UK, and Dublin, Ireland: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader in gene editing and […]

SAN DIEGO, CA and CAMBRIDGE, MA — Edico Genome and Seven Bridges today announced the availability of Edico Genome’s DRAGENTM pipelines within Seven Bridges’ cloud-based data ecosystem. Edico Genome’s DRAGEN Germline V2, DRAGEN Somatic V2 and DRAGEN RNA Gene Fusion Detection Pipelines are now live on the Seven Bridges platform, enabling customers to leverage DRAGEN’s ultra rapid speeds and accuracy. Seven Bridges […]

IPSWICH, Mass. and VILNIUS, Lithuania — New England Biolabs, Inc. (NEB®) and CasZyme, a recently-formed startup company based in Vilnius, Lithuania, announced today that they have entered into a multi-year collaboration to identify and commercialize CRISPR-Cas nucleases, with the goal of providing researchers with additional tools for genome editing and molecular biology applications. Under the terms of the agreement, […]

Our distributor agreement with BIOZOL expands the availability of the Novallele™ genotyping and copy number assays MELVILLE, N.Y. Canon BioMedical is pleased to announce our latest geographic expansion into the German-speaking countries of Austria, Germany, and Switzerland. We are working with a new distributor, BIOZOL Diagnostica Vertrieb GmbH, that will distribute all of the Novallele […]